Neurol. praxi. 2021;22(4):284-288 | DOI: 10.36290/neu.2021.013

Should we treat patients with chronic alcohol dependency by antiepileptics?

MUDr. Jana Zárubová
Neurologická klinika 2. LF UK a FN Motol, Praha
Neurologie, Medicon, a. s., Praha

Alcohol dependency syndrome is common in the Czech population. Neurologists encounter these patients during inpatient and outpatient care. One of the frequent health problems is the occurrence of epileptic seizures. People addicted to alcohol may have some type of epilepsy as well. The aim of the review article is to specify whether these are acute symptomatic seizures or clinical manifestation of epilepsy as a chronic disease and how to approach them in treatment. The therapy of withdrawal and addiction syndrome is briefly mentioned. Chronic administration of antiepileptic drugs is indicated in alcoholics in the case of diagnosed epilepsy and in the treatment of dependency. Following acute symptomatic seizures, the longterm administration of antiepileptic drugs is not warranted.

Keywords: alcohol dependence, withdrawal syndrome, acute symptomatic seizures, epilepsy, antiepileptic drugs.

Received: February 23, 2021; Revised: February 23, 2021; Accepted: March 4, 2021; Prepublished online: March 4, 2021; Published: September 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zárubová J. Should we treat patients with chronic alcohol dependency by antiepileptics? Neurol. praxi. 2021;22(4):284-288. doi: 10.36290/neu.2021.013.
Download citation

References

  1. Alho H. Potential of Ondansentron in Alcohol Use Disorder. 2020. https://touchneurology.com/psychiatric-disorders/conference-hub/hannu-alho-potential-of-ondansetron-in-alcohol-use-disorder-part-1/.
  2. Anton RF, Latham P, Voronin K, Book S, Hoffman M, Prisciandaro J, Bristol E. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial. JAMA Intern Med. 2020; 180(5):728-736. doi: 10.1001/jamainternmed.2020.0249. PMID: 32150232; PMCID: PMC7063541. Go to original source... Go to PubMed...
  3. Attilia F, Perciballi R, Rotondo C, Capriglione I, Iannuzzi S, Attilia ML, Coriale G, Vitali M, Cereatti F, Fiore M, Ceccanti M; Interdisciplinary Study Group CRARL - SITAC - SIPaD - SITD - SIPDip. Alcohol withdrawal syndrome: diagnostic and therapeutic methods. Riv Psichiatr. 2018; 53(3): 118-122. doi: 10.1708/2925.29413. PMID: 29912213. Go to original source... Go to PubMed...
  4. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010; 51(4): 671-5. doi: 10.1111/j.1528-1167.2009.02285.x. Epub 2009 Sep 3. PMID: 19732133. Go to original source... Go to PubMed...
  5. Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, Mazza M, Sarchiapone M, et al. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Hum Psychopharmacol. 2010; 25(3): 268-275. Go to original source... Go to PubMed...
  6. Freynhagen R, Backonja M, Schug S, Lyndon G, Parsons B, Watt S, Behar R. Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review. CNS Drugs. 2016; 30(12): 1191-1200. Go to original source... Go to PubMed...
  7. Hnilicová H, Dobiášová K. Alkohol z pohledu veřejného zdraví v ČR: fakta a souvislosti. Čas. Lék. čes. 2018; 157: 248-253.
  8. Jesse S, Bråthen G, Ferrara M, Keindl M, Ben-Menachem E, Tanasescu R, Brodtkorb E, Hillbom M, Leone MA, Ludolph AC. Alcohol withdrawal syndrome: mechanisms, manifestations, and management. Acta Neurol Scand. 2017; 135(1): 4-16. doi: 10.1111/ane.12671. Epub 2016 Sep 1. PMID: 27586815; PMCID: PMC6084325. Go to original source... Go to PubMed...
  9. Klinika adiktologie, přístup 31. ledna 2021. https://www.alkoholpodkontrolou.cz/co-uz-je-zavislost/skodlive-uzivani/
  10. Kolektiv autorů. Soubor minimálních diagnostických a terapeutických standardů u pacientů s epilepsií. Epileptický status a jeho léčba. EpiStop 2017: 27-29.
  11. Krijtová H, Krýsl D, Marusič P. Akutní symptomatické záchvaty a akutní status epilepticus - definice, příčiny a léčba. Neurol. praxi 2011; 12(4): 256-264.
  12. Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P. Efficacy and safety of pregabalin in alcohol dependence. Adv Ther. 2008; 25(6): 608-618. Go to original source... Go to PubMed...
  13. Mason BJ, Quello S, Goodell V, Shadan F, Kyle M, Begovic A. Gabapentin treatment for alcohol dependence: a randomized clinical trial. JAMA Intern Med. 2014; 174(1): 70-77. Go to original source... Go to PubMed...
  14. Muncie HL Jr, Yasinian Y, Oge' L. Outpatient management of alcohol withdrawal syndrome. Am Fam Physician. 2013; 88(9): 589-95. Go to PubMed...
  15. Myrick H, Malcolm R, Randall PK, Boyle E, Anton RF, Becker HC, et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009; 33(9): 1582-1588. Go to original source... Go to PubMed...
  16. Popov P. Závislost na alkoholu. Psychiatr. Praxi 2003; 1: 29-32.
  17. Šustková M. Závislost na návykových látkách ve Farmakologie. Praha: Grada 2018: 141-158.
  18. Tyrlíková I. Alkohol a epilepsie - jak léčit? Neurol. praxi 2013; 14(4): 197-199.
  19. Vodička M. Wernickeova encefalopatie. Neurol. praxi 2015; 16(6): 360-364.
  20. World Health Organization. Alcohol use topic site. Accessed January 31, 2021. https://www.euro.who.int/en/search?q=alcohol.
  21. Zárubová J, Komárek V. Antiepileptika v Compendium, léčiva používaná v podmínkách ČR, 5. vydání. 2018 Praha: Panax Co, s. r. o.: 231-260.
  22. Zárubová J, Těšinová J, Veberová M, Marusič P, Beňová B. Epileptologie a právo. EpiStop 2016: 7-8.




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.